Thymosin Alpha-1 / KPV is a dual-peptide research formulation combining two synthetic peptides studied in laboratory models involving immune regulation, inflammatory signaling, cellular communication, and epithelial biology. The combination provides researchers with a multi-component format for investigating distinct but related biological pathways associated with immune and inflammatory processes.

Thymosin Alpha-1 is a 28-amino-acid peptide studied for its interactions with immune-related cells and signaling pathways. Laboratory research has examined its relationship with T-cell activity, dendritic-cell function, cytokine signaling, Toll-like receptor pathways, and communication between innate and adaptive immune systems.

KPV is a three-amino-acid peptide fragment derived from alpha-melanocyte-stimulating hormone (α-MSH). Research involving KPV has focused on inflammatory signaling, cytokine-related pathways, epithelial response, mucosal biology, and cellular processes associated with gastrointestinal and dermal research models.

This formulation combines 10mg Thymosin Alpha-1 and 10mg KPV and is supplied in a nasal research format for controlled laboratory investigation involving immune signaling, inflammatory pathways, epithelial biology, and related cellular processes.